← Back to Search

Partners for Rheumatoid Arthritis (PARASS Trial)

N/A
Waitlist Available
Research Sponsored by Brigham and Women's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
billing diagnosis of rheumatoid arthritis (714.0) or seronegative inflammatory arthritis or a member of the BRASS and PACO studies at Brigham and Women's Hospital
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 6 months
Awards & highlights

PARASS Trial Summary

The goal of PARASS is to develop a network of increased social support for Rheumatoid Arthritis (RA) patients that will improve patient outcomes and further promote understanding of RA among physicians and patients in the clinic community. This will be accomplished with the development and implementation of Buddy pairing and one -on- one informational support to be called Patient-to-Patient Connection.

Eligible Conditions
  • Rheumatoid Arthritis

PARASS Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

PARASS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
change in functional status
change in medication adherence
Secondary outcome measures
change in fatigue
change in pain
change in self-efficacy

PARASS Trial Design

2Treatment groups
Active Control
Group I: ControlsActive Control1 Intervention
Controls will be BRASS patients who continue to receive regular care without being matched with a peer support partner.
Group II: PartnersActive Control1 Intervention
Patients who are matched with support partners and have a billing diagnosis of RA (714.0) or seronegative inflammatory arthritis who are enrolled in the Brigham and Women's Rheumatoid Arthritis Sequential Study (BRASS) or the Patient-Centered Outcomes Initiative (PACO)

Find a Location

Who is running the clinical trial?

Brigham and Women's HospitalLead Sponsor
1,612 Previous Clinical Trials
11,470,510 Total Patients Enrolled
23 Trials studying Rheumatoid Arthritis
588,922 Patients Enrolled for Rheumatoid Arthritis
AmgenIndustry Sponsor
1,370 Previous Clinical Trials
1,377,623 Total Patients Enrolled
43 Trials studying Rheumatoid Arthritis
108,946 Patients Enrolled for Rheumatoid Arthritis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Arthritis & RheumatismJournal
Development and Evaluation of a Scale to Measure Perceived Self-efficacy in People with Arthritis
Lorig, Kate, Robert L. Chastain, Elaine Ung, Stanford Shoor, and Halsted R. Holman. 1989. “Development and Evaluation of a Scale to Measure Perceived Self-efficacy in People with Arthritis”. Arthritis & Rheumatism. Wiley. doi:10.1002/anr.1780320107.
clinicaltrials.govStudy
Patient Rheumatoid Arthritis Social Support Study
Nancy Shadick 2009. "Patient Rheumatoid Arthritis Social Support Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01525654.
All > Rheumatoid Arthritis > Ra
~4 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top